Panacea Life Sciences Holdings, Inc.
Equity & Debt
| Fiscal Year | Long Term Debt | Share Holder Equity | Cash on Hand |
|---|---|---|---|
| FY2018 | $591.8K | $-3.4M | $2.0K |
| FY2019 | $185.9K | $7.5M | $18.4K |
| FY2020 | $335.5K | $1.8M | $84.4K |
| FY2021 | — | $7.1M | $19.8K |
| FY2022 | — | $-2.1M | $7.0K |
Equity & Debt
| Fiscal Year | Long Term Debt | Share Holder Equity | Cash on Hand |
|---|---|---|---|
| FY2018 | $591.8K | $-3.4M | $2.0K |
| FY2019 | $185.9K | $7.5M | $18.4K |
| FY2020 | $335.5K | $1.8M | $84.4K |
| FY2021 | — | $7.1M | $19.8K |
| FY2022 | — | $-2.1M | $7.0K |